The Revamped Pharmaceutical Technology Upgradation Assistance (RPTUAS) subsidy scheme offers both interest subvention and capital subsidy to help pharmaceutical manufacturing units upgrade to meet Revised Schedule M and WHO-GMP standards
Existing pharmaceutical units having average turnover less than Rs.500 crore over the last 3 years
Key Features
- Broadened Eligibility Criteria: Reflecting a more inclusive approach, eligibility for the PTUAS has been expanded beyond Micro, Small and Medium Enterprises to include any pharmaceutical manufacturing unit with a turnover of less than 500 crores that requires technology and quality upgradation. Preference remains for MSMEs, supporting smaller players in achieving high-quality manufacturing standards.
- Flexible Financing Options: The scheme introduces more flexible financing options, emphasizing subsidies on reimbursement basis, over traditional credit-linked approach. This flexibility is designed to diversify the financing options of the participating units, facilitating a more widespread adoption of the scheme.
- Comprehensive Support for Compliance with New Standards: In alignment with revised Schedule-M and WHO-GMP standards, the scheme now supports a broader range of technological upgrades. Eligible activities include improvements such as HVAC systems, water and steam utilities, testing laboratories, stability chambers, clean room facilities, effluent treatment, waste management etc. ensuring comprehensive support for participating units.
- Dynamic Incentive Structure: Pharmaceutical units with the following average turnover for the last three years will be eligible for incentive subject to a maximum of Rs. 1.00 crore per unit:
Expenditure incurred on items below will only be considered for calculation of subsidy amount to the Pharma units:-
a. Utilities (HVAC, Water,
Steam)
b. Clean Room Facility
c. Testing Lab, Stability Chamber
d. Effluent treatment/Waste Management
e. Production Equipment
f. Consultation/Certification Expenses
g. Any other item with the recommendation of the Technical Committee
Incentive under the scheme
Pharmaceutical units with following average turnover criterion for the last three years will be eligible for incentive subject to a maximum of Rs. 2.00 crore as under:-
- Turnover from Rs. 1.00 crore to less than Rs. 50.00 crore – 20% of investment under eligible activities;
- Turnover from Rs. 50.00 crore to less than Rs. 250.00 crore:- 15% of investment under eligible activities;
- Turnover from Rs. 50.00 crore to less than Rs. 250.00 crore – 15% of investment under eligible activities;500.00 crore:- 10% of investment under eligible activities;
The SSC will consider the recommendation of the PMC regarding the subsidy amount for each applicant and 50% of the eligible amount (subject to an upper limit of Rs. 1.00 crore) will be released as 1st installment within 30 days of obtaining requisite documents
The SSC will consider the recommendations of the PMC regarding the 2nd and final installment of the subsidy and approve the release of eligible amount (subject to total upper limit of Rs. 2.00 crore for each applicant) within 30 days of obtaining the requisite documents.
